Argent Trust CO Alnylam Pharmaceuticals, Inc. Transaction History

Argent Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$120.42 - $169.29 $95,974 - $134,924	-797 Reduced 36.46%	1,389 $203,000
Q1 2022 May 11, 2022	SELL	$127.18 - $173.91 $9,029 - $12,347	-71 Reduced 3.15%	2,186 $358,000
Q4 2021 Feb 09, 2022	BUY	$159.56 - $209.29 $4,946 - $6,487	31 Added 1.39%	2,257 $383,000
Q3 2021 Nov 09, 2021	BUY	$169.75 - $207.73 $11,543 - $14,125	68 Added 3.15%	2,226 $421,000
Q2 2021 Aug 09, 2021	BUY	$128.63 - $176.89 $17,879 - $24,587	139 Added 6.88%	2,158 $366,000
Q1 2021 May 12, 2021	BUY	$126.83 - $175.69 $256,069 - $354,718	2,019 New	2,019 $285,000

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

Stay updated on Argent Trust CO with notifications on news.